Second quarter revenue rose 9.6% year-over-year to $71.3 million, with record wholesale revenue and strong retail growth in Ohio and Virginia. Federal rescheduling of medical cannabis led to a $6.4 million tax benefit, and Virginia adult use legalization positions the company for future growth.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.